FOLH1 and hepatocellular carcinoma: The resulting compound was labeled with both 18F and 68Ga in murine HCC models and the dual-imaging probe achieved tumor uptakes 30–60% higher than monomeric GPC3 or PSMA tracers, with tumor-to-muscle ratios exceeding 4:1 at 90 min post-injection.